Structure and function of glutamate receptor amino terminal domains

Journal of Physiology

Volumn 590, Issue 1, 2012, Pages 63-72

  Furukawa, Hiro ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; IFENPRODIL; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ENZYME ACTIVITY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SUBUNIT; REVIEW; STRUCTURE ANALYSIS;

HUMANS; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IONOTROPIC GLUTAMATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84855166359     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.213850     Document Type: Review

References (53)

1. Armstrong N & Gouaux E (2000). Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28, 165-181.
2. Armstrong N, Jasti J, Beich-Frandsen M & Gouaux E (2006). Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor. Cell 127, 85-97.
3. Armstrong N, Sun Y, Chen GQ & Gouaux E (1998). Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 395, 913-917.
4. Atlason PT, Garside ML, Meddows E, Whiting P & McIlhinney RA (2007). N-Methyl-D-aspartate (NMDA) receptor subunit NR1 forms the substrate for oligomeric assembly of the NMDA receptor. J Biol Chem 282, 25299-25307.
5. Carron C, Jullien A & Bucher B (1971). Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives. Arzneimittelforschung 21, 1992-1998.
6. 2+ inhibition of the NMDA receptor. Neuron 23, 171-180.
7. Cisse M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P, et al (2011). Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469, 47-52.
8. Clayton A, Siebold C, Gilbert RJ, Sutton GC, Harlos K, McIlhinney RA, Jones EY & Aricescu AR (2009). Crystal structure of the GluR2 amino-terminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors. J Mol Biol 392, 1125-1132.
9. Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW & Greenberg ME (2000). EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103, 945-956.
10. Das U, Kumar J, Mayer ML & Plested AJ (2010). Domain organization and function in GluK2 subtype kainate receptors. Proc Natl Acad Sci U S A 107, 8463-8468.
11. Farina AN, Blain KY, Maruo T, Kwiatkowski W, Choe S & Nakagawa T (2011). Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors. J Neurosci 31, 3565-3579.
12. 2+ binding to NMDA receptors. Neuron 25, 683-694.
13. Furukawa H & Gouaux E (2003). Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J 22, 2873-2885.
14. Furukawa H, Singh SK, Mancusso R & Gouaux E (2005). Subunit arrangement and function in NMDA receptors. Nature 438, 185-192.
15. Gielen M, Le Goff A, Stroebel D, Johnson JW, Neyton J & Paoletti P (2008). Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition. Neuron 57, 80-93.
16. Gielen M, Siegler Retchless B, Mony L, Johnson JW & Paoletti P (2009). Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459, 703-707.
17. Hansen KB, Furukawa H & Traynelis SF (2010). Control of assembly and function of glutamate receptors by the amino-terminal domain. Mol Pharmacol 78, 535-549.
18. Inanobe A, Furukawa H & Gouaux E (2005). Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron 47, 71-84.
19. Jin R, Clark S, Weeks AM, Dudman JT, Gouaux E & Partin KM (2005). Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci 25, 9027-9036.
20. Jin R, Singh SK, Gu S, Furukawa H, Sobolevsky AI, Zhou J, Jin Y & Gouaux E (2009). Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J 28, 1812-1823.
21. Kandel ER, Schwartz JH & Jessel TM (1995). Essentials of Neural Science and Behavior. Appelton & Lange, East Norwalk
22. Karakas E, Simorowski N & Furukawa H (2009). Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 28, 3910-3920.
23. Karakas E, Simorowski N & Furukawa H (2011). Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 475, 249-253.
24. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, et al. (2009). Predicting new molecular targets for known drugs. Nature 462, 175-181.
25. Kew JN, Trube G & Kemp JA (1996). A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497, 761-772.
26. Koller M & Urwyler S (2010). Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006. Expert Opin Ther Pat 20, 1683-1702.
27. Kumar J & Mayer ML (2010). Crystal structures of the glutamate receptor ion channel GluK3 and GluK5 amino-terminal domains. J Mol Biol 404, 680-696.
28. Kumar J, Schuck P, Jin R & Mayer ML (2009). The N-terminal domain of GluR6-subtype glutamate receptor ion channels. Nat Struct Mol Biol 16, 631-638.
29. Kumar J, Schuck P & Mayer ML (2011). Structure and assembly mechanism for heteromeric kainate receptors. Neuron 71, 319-331.
30. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H & Morikawa K (2000). Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971-977.
31. Lee CH & Gouaux E (2011). Amino terminal domains of the NMDA receptor are organized as local heterodimers. PloS One 6, e19180.
32. Lester RA, Clements JD, Westbrook GL & Jahr CE (1990). Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents. Nature 346, 565-567.
33. Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, et al (2003). Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating. Mol Pharmacol 63, 1212-1222.
34. Low CM, Zheng F, Lyuboslavsky P & Traynelis SF (2000). Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc Natl Acad Sci U S A 97, 11062-11067.
35. Mayer ML (2005). Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron 45, 539-552.
36. Mony L, Kew JN, Gunthorpe MJ & Paoletti P (2009). Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 157, 1301-1317.
37. Nakagawa T, Cheng Y, Ramm E, Sheng M & Walz T (2005). Structure and different conformational states of native AMPA receptor complexes. Nature 433, 545-549.
38. Nolt MJ, Lin Y, Hruska M, Murphy J, Sheffler-Colins SI, Kayser MS, Passer J, Bennett MV, Zukin RS & Dalva MB (2011). EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner. J Neurosci 31, 5353-5364.
39. Paoletti P (2011). Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33, 1351-1365.
40. Paoletti P, Ascher P & Neyton J (1997). High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17, 5711-5725.
41. Quiocho FA & Ledvina PS (1996). Atomic structure and specificity of bacterial periplasmic receptors for active transport and chemotaxis: variation of common themes. Mol Microbiol 20, 17-25.
42. Rachline J, Perin-Dureau F, Le Goff A, Neyton J & Paoletti P (2005). The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J Neurosci 25, 308-317.
43. Saglietti L, Dequidt C, Kamieniarz K, Rousset MC, Valnegri P, Thoumine O, Beretta F, Fagni L, Choquet D, Sala C, et al (2007). Extracellular interactions between GluR2 and N-cadherin in spine regulation. Neuron 54, 461-477.
44. Sobolevsky AI, Rosconi MP & Gouaux E (2009). X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462, 745-756.
45. Stroebel D, Carvalho S & Paoletti P (2011). Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain. Neuropharmacology 60, 151-158.
46. Sukumaran M, Rossmann M, Shrivastava I, Dutta A, Bahar I & Greger IH (2011). Dynamics and allosteric potential of the AMPA receptor N-terminal domain. EMBO J 30, 972-982.
47. Sun Y, Olson R, Horning M, Armstrong N, Mayer M & Gouaux E (2002). Mechanism of glutamate receptor desensitization. Nature 417, 245-253.
48. Takasu MA, Dalva MB, Zigmond RE & Greenberg ME (2002). Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 295, 491-495.
49. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R, et al (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62, 405-496.
50. 3+. Proc Natl Acad Sci U S A 99, 2660-2665.
51. Vance KM, Simorowski N, Traynelis SF & Furukawa H (2011). Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. Nature Commun 2, 294.
52. Yao Y, Harrison CB, Freddolino PL, Schulten K & Mayer ML (2008). Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors. EMBO J 27, 2158-2170.
53. Yuan H, Hansen KB, Vance KM, Ogden KK & Traynelis SF (2009). Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 29, 12045-12058.